FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of producing [18F]flutemetamol, involving steps of (a) reacting a compound of general formula (1) with radioactive fluoride to obtain a reaction mixture, containing a compound represented by the following general formula (2), and a compound represented by the following general formula (1); (b) exposing the strong base to the reaction mixture obtained in step (a); (c) purifying the compound of general formula (2), after step (b) using the reversed-phase solid-phase extraction cartridge and (d) removing both protective groups to obtain [18F]flutemetamol, where R1 is a protecting group for a hydroxy group, and C(O)R2 is a protective group for an amino group, where R1 and R2 have same values as in a compound represented by general formula (1).
EFFECT: technical result is production of [18F]flutemetamol with high output.
8 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RADIO-LABELING | 2014 |
|
RU2690848C2 |
METHOD OF PRODUCING FLUORINE-SUBSTITUTED ORGANIC ALIPHATIC COMPOUND AND METHOD OF PURIFYING FLUORINE-SUBSTITUTED ORGANIC ALIPHATIC COMPOUND | 2015 |
|
RU2710558C2 |
ELUENT SOLUTION | 2011 |
|
RU2608932C2 |
METHOD OF 18F-LABELED BIOMOLECULES SYNTHESIS | 2012 |
|
RU2620598C2 |
METHOD OF PRODUCING RADIOACTIVE FLUORINE-LABELLED ORGANIC COMPOUND | 2007 |
|
RU2434846C2 |
METHOD OF PRODUCING RADIOACTIVE, FLUORINE-LABELLED ORGANIC COMPOUND | 2008 |
|
RU2476423C2 |
NOVEL PRECURSORS OF GLUTAMATE DERIVATIVES | 2012 |
|
RU2600981C2 |
PRODUCTION OF F-FLUCYCLOWINE | 2013 |
|
RU2640805C2 |
NUCLEOPHILIC FLUORINATION IN SOLID PHASE | 2002 |
|
RU2315769C9 |
REAGENTS AND METHODS FOR RADIOACTIVE LABELLING | 2010 |
|
RU2524284C2 |
Authors
Dates
2020-10-01—Published
2016-10-17—Filed